V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008498 | 220003412 | 1.74 | 114 | Palliative (P) | 2014-10-25 | 2014-10-30 | EOX | 02 | N | 220034644 | EOX |
| 220008499 | 220011879 | 1.8 | null | Palliative (P) | 2017-05-04 | 2017-05-26 | EOX | N | N | 220034648 | EOX |
| 220008500 | 220011879 | null | 63 | Palliative (P) | 2015-07-13 | 2015-08-03 | CAPECITABINE + OXALIPLATIN | N | null | 220034648 | CAPECITABINE + OXALIPLATIN |
| 220008501 | 220003413 | 0 | null | Palliative (P) | 2016-02-23 | 2016-02-25 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 220034652 | GEMCITABINE |
| 220008502 | 220003413 | 1.61 | null | Palliative (P) | 2017-10-15 | 2017-10-30 | Oxaliplatin + Modified de Gramont | 1 | Y | 220034652 | OXALIPLATIN + MDG |
| 220008503 | 220003414 | null | 82 | Palliative (P) | 2016-10-18 | 2016-10-21 | Carboplatin + Etoposide IV 3 day | 02 | N | 220034655 | CARBOPLATIN + ETOPOSIDE |
| 220008504 | 220011881 | null | 80 | Curative (C) | 2013-09-01 | 2013-09-01 | FLAG | null | N | 220034659 | FLAG |
| 220008505 | 220011881 | 1.58 | 74.3 | Curative (C) | null | 2016-03-08 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034659 | ADE |
| 220008506 | 220011881 | 1.63 | 121.2 | Curative (C) | 2015-01-30 | 2015-01-30 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034659 | ADE |
| 220008507 | 220011881 | null | 81.1 | null | 2014-10-03 | 2014-10-24 | CAPECITABINE + OXALIPLATIN | N | N | 220034659 | CAPECITABINE + OXALIPLATIN |
| 220008508 | 220003415 | 1.64 | 81 | Curative (C) | 2017-11-05 | 2017-11-08 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034664 | ADE |
| 220008509 | 220003416 | 1.45 | 71.4 | Palliative (P) | 2015-01-04 | 2015-01-07 | PEMBROLIZUMAB | N | null | 220034667 | GEMCITABINE |
| 220008510 | 220003417 | 1.73 | 72 | Palliative (P) | 2013-02-28 | 2013-03-19 | Carboplatin AUC 2 - 5 | N | N | 220034669 | CARBOPLATIN |
| 220008511 | 220003417 | 1.72 | 56.1 | Palliative (P) | 2013-03-02 | 2013-03-20 | ECX | N | N | 220034669 | ECX |
| 220008512 | 220003417 | 1.78 | 57.2 | Palliative (P) | null | 2014-07-30 | CARBOPLATIN + ETOPOSIDE | N | null | 220034669 | CARBOPLATIN + ETOPOSIDE |
| 220008513 | 220003417 | null | 69 | Curative (C) | 2014-11-08 | 2014-12-02 | Cisplatin + Radiotherapy | N | N | 220034669 | CISPLATIN + RT |
| 220008514 | 220003418 | 1.65 | 38.9 | null | 2015-05-21 | 2015-05-21 | RAVVA TRIAL | 02 | N | 220034675 | GEMCITABINE |
| 220008515 | 220003419 | 1.78 | 8.5 | Curative (C) | 2015-09-01 | 2015-09-03 | FLAG | 2 | N | 220034676 | FLAG |
| 220008516 | 220003420 | 1.84 | 73 | Palliative (P) | 2015-07-07 | 2015-07-09 | CARBOPLATIN | N | N | 220034677 | CARBOPLATIN |
| 220008517 | 220003421 | 1.65 | 83.6 | Palliative (P) | 2017-09-17 | 2017-09-19 | Carboplatin + Etoposide IV 3 day | N | N | 220034678 | CARBOPLATIN + ETOPOSIDE |
| 220008518 | 220003421 | null | 77.8 | Palliative (P) | 2014-12-09 | 2014-12-10 | Carboplatin + Etoposide iv&po | N | null | 220034678 | CARBOPLATIN + ETOPOSIDE |
| 220008519 | 220003421 | 0 | 65 | Palliative (P) | 2017-01-13 | 2017-01-13 | CAPECITABINE + OXALIPLATIN | N | N | 220034678 | CAPECITABINE + OXALIPLATIN |
| 220008520 | 220003421 | 1.48 | 66.3 | Palliative (P) | 2013-07-07 | 2013-07-15 | ECX | N | N | 220034678 | ECX |
| 220008521 | 220003421 | 1.8 | 59.8 | null | 2017-12-22 | 2017-12-23 | Carboplatin AUC 2 - 5 | N | N | 220034678 | CARBOPLATIN |
| 220008522 | 220003422 | null | 84.7 | Disease modification (D) | null | 2017-05-12 | GEMCITABINE | null | null | 220034686 | RITUXIMAB |
| 220008523 | 220003423 | null | 64.7 | null | null | 2014-10-22 | Cytarabine High Dose | 1 | N | 220034687 | CYTARABINE HIGH DOSE |
| 220008524 | 220003423 | 0 | 70 | Curative (C) | 2015-07-22 | 2015-09-09 | Cytarabine High Dose | N | N | 220034687 | CYTARABINE HIGH DOSE |
| 220008525 | 220003423 | 1.69 | 78.3 | Disease modification (D) | 2016-01-25 | 2016-02-15 | RAVVA TRIAL | 02 | Y | 220034687 | RITUXIMAB |
| 220008526 | 220003423 | 0.99 | null | Curative (C) | 2017-07-04 | 2017-10-31 | Cytarabine High Dose | 01 | Y | 220034687 | CYTARABINE HIGH DOSE |
| 220008527 | 220003424 | null | 90 | Palliative (P) | 2014-10-20 | 2014-10-24 | RAVVA TRIAL | null | N | 220034692 | RITUXIMAB |
| 220008528 | 220011885 | 1.67 | 72.3 | T | 2013-08-09 | 2013-08-10 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220034693 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008529 | 220011885 | 1.83 | 82 | Palliative (P) | 2016-06-21 | 2016-06-26 | Rituximab | 2 | N | 220034693 | RAVVA TRIAL |
| 220008530 | 220011885 | 1.65 | 61 | Palliative (P) | null | 2015-05-11 | Carboplatin + Etoposide iv&po | N | N | 220034693 | CARBOPLATIN + ETOPOSIDE |
| 220008531 | 220011885 | 1.6 | 70 | Palliative (P) | 2013-06-26 | 2013-06-27 | ECX | N | N | 220034693 | ECX |
| 220008532 | 220003425 | null | 92.85 | Palliative (P) | 2014-09-08 | 2014-09-13 | EOX | N | N | 220034699 | EOX |
| 220008533 | 220003425 | 1.64 | 8.8 | Palliative (P) | 2017-02-19 | 2017-02-20 | FLUOROURACIL + OXALIPLATIN | N | Y | 220034699 | OXALIPLATIN + MDG |
| 220008534 | 220003425 | 1.6 | 58 | Palliative (P) | 2017-07-16 | 2017-08-23 | Cytarabine High Dose | N | N | 220034699 | CYTARABINE HIGH DOSE |
| 220008535 | 220003425 | 1.94 | 67 | Palliative (P) | 2014-06-30 | 2014-07-19 | EOX | Y | null | 220034699 | EOX |
| 220008536 | 220003425 | 1.75 | 108.9 | Palliative (P) | null | 2014-09-09 | Carboplatin + Etoposide iv&po | 02 | N | 220034699 | CARBOPLATIN + ETOPOSIDE |
| 220008537 | 220021315 | null | 90.9 | Not known (9) | 2016-01-11 | 2016-04-10 | Cytarabine High Dose | null | null | 220034707 | CYTARABINE HIGH DOSE |
| 220008538 | 220003426 | 1.56 | 93.2 | Palliative (P) | 2015-08-13 | 2015-08-20 | EOX | 2 | N | 220034711 | EOX |
| 220008539 | 220003427 | 1.79 | 52 | Curative (C) | 2015-06-14 | 2015-06-19 | FLAG | N | N | 220034712 | FLAG |
| 220008540 | 220003428 | 1.65 | 51 | Palliative (P) | null | 2014-08-13 | Capecitabine + Oxaliplatin 21day | 2 | Y | 220034713 | CAPECITABINE + OXALIPLATIN |
| 220008541 | 220011887 | null | 76 | Disease modification (D) | 2014-08-19 | 2014-08-20 | AML Int Guide ADE 10+3+5 (1) | null | null | 220034714 | ADE |
| 220008542 | 220003429 | 1.63 | 78 | null | null | 2013-03-08 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034715 | ADE |
| 220008543 | 220003430 | 1.59 | 73.5 | Palliative (P) | null | 2015-12-12 | EOX | 02 | N | 220034716 | EOX |
| 220008544 | 220003430 | null | 62.2 | Palliative (P) | 2014-01-15 | 2014-01-27 | Carboplatin + Etoposide IV 3 day | N | N | 220034716 | CARBOPLATIN + ETOPOSIDE |
| 220008545 | 220003431 | null | 60.6 | Palliative (P) | 2014-12-18 | 2014-12-20 | Capecitabine + Oxaliplatin 21day | N | null | 220034719 | CAPECITABINE + OXALIPLATIN |
| 220008546 | 220003432 | 1.7 | 59 | Palliative (P) | 2014-12-05 | 2015-01-03 | CARBOPLATIN | null | N | 220034720 | CARBOPLATIN |
| 220008547 | 220003433 | 1.8 | 60.2 | Palliative (P) | 2015-10-18 | 2015-10-18 | Rituximab | 02 | Y | 220034722 | RAVVA TRIAL |